431-440 of 626 results
Allens advises Computer Sciences Corporation on the acquisition of UXC Ltd
Allens has advised global IT services provider, Computer Sciences Corporation (CSC), on the $427.6 million acquisition of UXC Ltd (UXC), Australia's largest publicly-owned IT services company. CSC ...
Allens advises Archer Capital on sale of Healthe Care
Allens has advised Archer Capital on its proposed divestment of private hospital business Healthe Care to China's Luye Medical Group. Healthe Care is Australia's third largest private hospital ...
Dixon Hospitality says cheers to Beer DeLuxe
Allens has advised Dixon Hospitality on its acquisition of the Beer DeLuxe venues in NSW and Victoria. Dixon has acquired six venues including those in the entertainment precincts of King Street ...
Allens advises Public Transport Victoria on myki re-tendering
In one of the largest and most complex government tender processes in Australia, Allens has advised Public Transport Victoria on the competitive tender for the operation of the myki ticketing syste ...
Allens advises Healthe Care on two major acquisitions
Allens has advised leading Australian private hospital operator Healthe Care Australia in relation to the acquisition of ASX-listed Pulse Health Limited and three hospitals in the Illawarra region ...
Allens advises Westpac on zipMoney investment
Allens has advised Westpac on its $40 million investment in listed Fintech zipMoney. The deal includes a $40 million equity investment, a grant of up to 9.8 million performance options and a ...
The High Court has its say on penalties
The high court handed down its decision in Paciocco v Australia and New Zealand banking group limited. ...
What's in a (biosimilar) name?
Because biosimilars and their reference biologic medicine are not identical whether compared to each other or even between biosimilars it is important to know which product has been used ...
Protecting investment in biologic medicines - biological medicines, biosimilars and the challenges they pose
This series of articles is directed towards the part of biotech that is pharmaceutical rather than diagnostic or bioengineering technologies and in particular towards biologic medicines ...
The efficacy of e-signatures
Allens has adopted e-signature using DocuSign as a service to clients. Senior Finance Counsel Diccon Loxton has written an article in two parts that examines the efficacy of e-signatures. ...